[Pharmacological regulation of the activity of lymphokines].
D000262:Adenylyl Cyclases / Q000502:physiology; D000287:Administration, Topical; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000961:Antilymphocyte Serum / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D003571:Cytochalasin B / Q000494:pharmacology; D004789:Enzyme Activation; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D006854:Hydrocortisone; D007372:Interferons / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D007978:Levamisole / Q000494:pharmacology; D008222:Lymphokines / Q000502:physiology* / Q000528:radiation effects; D008264:Macrophages / Q000276:immunology*; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D005343:Fibrinolytic Agents; D008222:Lymphokines; D011459:Prostaglandins E, Synthetic; D007978:Levamisole; D003571:Cytochalasin B; D007372:Interferons; D013806:Theophylline; D000262:Adenylyl Cyclases; D007545:Isoproterenol; D006854:Hydrocortisone
Farmakologiczna regulacja aktywności limfokin.